CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Ionis Pharmaceuticals, Inc. - IONS CFD

35.45
0.77%
0.19
Rendah: 35.13
Tinggi: 35.9
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.19
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 35.18
Open* 35.2
1-Year Change* -0.17%
Day's Range* 35.13 - 35.9
52 wk Range 31.46-48.82
Average Volume (10 days) 851.96K
Average Volume (3 months) 19.47M
Market Cap 5.03B
P/E Ratio -100.00K
Shares Outstanding 142.95M
Revenue 587.37M
EPS -1.90
Dividend (Yield %) N/A
Beta 0.54
Next Earnings Date May 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 20, 2023 35.45 -0.31 -0.87% 35.76 36.04 35.03
Mar 17, 2023 35.04 0.77 2.25% 34.27 35.20 33.70
Mar 16, 2023 34.86 1.50 4.50% 33.36 35.00 33.36
Mar 15, 2023 34.15 0.99 2.99% 33.16 34.18 32.63
Mar 14, 2023 33.74 0.43 1.29% 33.31 33.88 32.39
Mar 13, 2023 33.50 0.15 0.45% 33.35 34.65 33.35
Mar 10, 2023 33.91 0.05 0.15% 33.86 34.75 33.52
Mar 9, 2023 34.62 -0.80 -2.26% 35.42 35.72 34.28
Mar 8, 2023 35.62 0.12 0.34% 35.50 35.83 35.15
Mar 7, 2023 35.65 -0.22 -0.61% 35.87 36.14 35.49
Mar 6, 2023 36.12 -0.10 -0.28% 36.22 36.63 35.81
Mar 3, 2023 36.45 0.91 2.56% 35.54 36.71 35.01
Mar 2, 2023 35.66 0.39 1.11% 35.27 35.84 35.07
Mar 1, 2023 35.89 0.28 0.79% 35.61 36.31 34.93
Feb 28, 2023 35.71 0.62 1.77% 35.09 36.58 34.60
Feb 27, 2023 36.08 0.24 0.67% 35.84 36.38 34.90
Feb 24, 2023 35.56 -0.50 -1.39% 36.06 36.16 35.25
Feb 23, 2023 36.50 0.65 1.81% 35.85 36.82 34.92
Feb 22, 2023 36.74 -1.03 -2.73% 37.77 38.21 35.46
Feb 21, 2023 38.08 -0.30 -0.78% 38.38 38.60 36.84

Ionis Pharmaceuticals, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 810.456 729.264 1122.6 599.674 514.179
Revenue 810.456 729.264 1122.6 599.674 514.179
Cost of Revenue, Total 10.842 11.947 4.384 1.82 0
Gross Profit 799.614 717.317 1118.21 597.854 514.179
Total Operating Expense 849.269 901.346 822.912 661.046 490.821
Selling/General/Admin. Expenses, Total 170.947 332.222 286.644 244.622 108.488
Research & Development 634.953 526.877 465.688 414.604 374.644
Unusual Expense (Income) 32.527 30.3 66.196 0 7.689
Operating Income -38.813 -172.082 299.687 -61.372 23.358
Interest Income (Expense), Net Non-Operating 10.798 37.592 39.765 -14.602 -36.573
Other, Net -1.133 -0.062 -0.686 -0.182 -3.548
Net Income Before Taxes -29.148 -134.552 338.766 -76.156 -16.763
Net Income After Taxes -28.597 -479.743 287.259 -117.115 96.517
Minority Interest 0 35.48 -9.116 58.756 11.129
Net Income Before Extra. Items -28.597 -444.263 278.143 -58.359 107.646
Net Income -28.597 -444.263 278.143 273.741 0.346
Income Available to Common Excl. Extra. Items -28.597 -444.263 278.143 -58.359 107.646
Income Available to Common Incl. Extra. Items -28.597 -444.263 278.143 273.741 0.346
Dilution Adjustment 0 0
Diluted Net Income -28.597 -444.263 278.143 273.741 0.346
Diluted Weighted Average Shares 141.021 139.612 153.164 134.056 126.098
Diluted EPS Excluding Extraordinary Items -0.20279 -3.18213 1.81598 -0.43533 0.85367
Diluted Normalized EPS -0.05286 -3.04106 2.18246 -0.43533 0.8933
Total Extraordinary Items 332.1 -107.3
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 141.919 440.006 133.093 125.75 111.607
Revenue 141.919 440.006 133.093 125.75 111.607
Cost of Revenue, Total 4.17 2.226 3.079 2.958 2.578
Gross Profit 137.749 437.78 130.014 122.792 109.029
Total Operating Expense 199.423 219.401 218.942 207.346 203.578
Selling/General/Admin. Expenses, Total 34.127 37.6 31.093 56.455 61.199
Research & Development 161.126 179.575 184.77 139.306 139.801
Operating Income -57.504 220.605 -85.849 -81.596 -91.971
Interest Income (Expense), Net Non-Operating -6.754 4.788 2.545 1.237 2.229
Other, Net 0.187 -0.477 -0.469 -0.189 0.003
Net Income Before Taxes -64.071 224.916 -83.773 -80.548 -89.739
Net Income After Taxes -65.165 224.613 -82.466 -80.875 -89.869
Minority Interest 0 0 0 0
Net Income Before Extra. Items -65.165 224.613 -82.466 -80.875 -89.869
Net Income -65.165 224.613 -82.466 -80.875 -89.869
Income Available to Common Excl. Extra. Items -65.165 224.613 -82.466 -80.875 -89.869
Income Available to Common Incl. Extra. Items -65.165 224.613 -82.466 -80.875 -89.869
Diluted Net Income -65.165 224.613 -82.466 -80.875 -89.869
Diluted Weighted Average Shares 141.599 141.21 141.139 140.962 140.77
Diluted EPS Excluding Extraordinary Items -0.46021 1.59063 -0.58429 -0.57374 -0.63841
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.46021 1.59063 -0.58429 -0.53396 -0.63841
Unusual Expense (Income) 0 0 8.627
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 2345.05 2130.71 2720.6 2207.89 1168.73
Cash and Short Term Investments 2114.97 1892.38 2499.54 2084.07 1022.72
Cash & Equivalents 869.191 397.664 683.287 278.82 129.63
Short Term Investments 1245.78 1494.71 1816.26 1805.25 893.085
Total Receivables, Net 61.896 76.204 63.034 12.759 62.955
Accounts Receivable - Trade, Net 61.896 76.204 63.034 12.759 62.955
Total Inventory 24.806 21.965 18.18 8.582 9.982
Other Current Assets, Total 143.374 140.163 139.839 102.473 73.082
Total Assets 2611.69 2389.75 3233.11 2667.78 1322.77
Property/Plant/Equipment, Total - Net 196.069 181.077 166.251 132.16 121.907
Property/Plant/Equipment, Total - Gross 298.722 240.264 193.634 209.583
Accumulated Depreciation, Total -102.653 -74.013 -61.474 -87.676
Intangibles, Net 29.005 27.937 25.674 24.032 22.004
Other Long Term Assets, Total 41.567 50.034 320.59 303.706 10.129
Total Current Liabilities 240.55 598.898 273.005 280.294 243.612
Accounts Payable 11.904 17.199 16.067 28.66 24.886
Accrued Expenses 129.97 155.889 106.152 77.629 91.769
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.926 316.11 13.749 1.621
Other Current Liabilities, Total 97.75 109.7 150.786 160.256 125.336
Total Liabilities 1839.95 1646.47 1762.02 1619.7 1041.76
Total Long Term Debt 1228.02 623.529 770.3 632.971 605.856
Long Term Debt 1228.02 623.529 770.3 632.971 605.856
Capital Lease Obligations
Other Liabilities, Total 371.379 424.046 505.26 567.359 108.026
Total Equity 771.737 743.282 1471.09 1048.08 281.013
Common Stock 0.141 0.14 0.14 0.138 0.125
Additional Paid-In Capital 1964.17 1895.52 2203.78 2047.25 1553.68
Retained Earnings (Accumulated Deficit) -1159.9 -1131.31 -707.534 -967.293 -1241.03
Other Equity, Total -32.668 -21.071 -25.29 -32.016 -31.759
Total Liabilities & Shareholders’ Equity 2611.69 2389.75 3233.11 2667.78 1322.77
Total Common Shares Outstanding 141.21 140.366 140.34 137.929 124.976
Minority Interest 213.453 139.081 84.267
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 2253.12 2345.05 2155.74 2238.42 1989.42
Cash and Short Term Investments 2052.39 2114.97 1987.1 2059.27 1819.99
Cash & Equivalents 542.513 869.191 632.953 565.119 414.155
Short Term Investments 1509.88 1245.78 1354.15 1494.15 1405.84
Total Receivables, Net 26.122 61.896 9.068 24.004 23.397
Accounts Receivable - Trade, Net 26.122 61.896 9.068 24.004 23.397
Total Inventory 24.032 24.806 22.93 24.099 22.199
Other Current Assets, Total 150.577 143.374 136.643 131.045 123.827
Total Assets 2519.09 2611.69 2414.89 2497.07 2248.55
Property/Plant/Equipment, Total - Net 177.724 196.069 180.144 179.316 180.413
Intangibles, Net 29.295 29.005 30.038 29.373 28.795
Other Long Term Assets, Total 58.949 41.567 48.971 49.962 49.925
Total Current Liabilities 228.45 240.55 279.778 293.825 295.105
Accounts Payable 16.125 11.904 8.357 14.658 9.506
Accrued Expenses 115.781 129.97 108.001 105.372 108.029
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.206 0.926 65.045 69.848 69.504
Other Current Liabilities, Total 92.338 97.75 98.375 103.947 108.066
Total Liabilities 1809.52 1839.95 1884.36 1914.4 1567.99
Total Long Term Debt 1247.93 1228.02 1241.69 1240.7 870.916
Long Term Debt 1247.93 1228.02 1241.69 1240.7 870.916
Other Liabilities, Total 333.138 371.379 362.887 379.874 401.966
Total Equity 709.574 771.737 530.536 582.674 680.564
Common Stock 0.142 0.141 0.141 0.141 0.141
Additional Paid-In Capital 1983.08 1964.17 1942.35 1910.38 1925.8
Retained Earnings (Accumulated Deficit) -1225.07 -1159.9 -1384.52 -1302.05 -1221.18
Other Equity, Total -48.578 -32.668 -27.437 -25.796 -24.203
Total Liabilities & Shareholders’ Equity 2519.09 2611.69 2414.89 2497.07 2248.55
Total Common Shares Outstanding 141.753 141.21 141.184 141.022 140.924
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -28.597 -479.743 287.259 214.985 -10.783
Cash From Operating Activities 30.799 35.892 345.627 602.906 174.149
Cash From Operating Activities 15.487 13.365 12.54 10.706 6.708
Amortization 2.352 2.064 1.912 1.822 1.641
Deferred Taxes 0 341.729 0.911 -290.516 0
Non-Cash Items 155.375 232.032 211.806 166.484 139.539
Cash Interest Paid 4.778 6.247 9.87 9.592 8.035
Changes in Working Capital -113.818 -73.555 -168.801 499.425 37.044
Cash From Investing Activities 194.906 274.477 -41.274 -929.563 -358.291
Capital Expenditures -11.955 -35.12 -30.905 -13.608 -34.764
Other Investing Cash Flow Items, Total 206.861 309.597 -10.369 -915.955 -323.527
Cash From Financing Activities 245.933 -596.609 100.021 475.865 229.087
Financing Cash Flow Items -168.954 -558.097 -138.354 0 47.963
Issuance (Retirement) of Stock, Net 101.317 -38.512 141.375 475.865 205.106
Issuance (Retirement) of Debt, Net 313.57 0 97 0 -23.982
Net Change in Cash 471.527 -285.623 404.467 149.19 44.945
Cash Taxes Paid 0.038 25.855 9.041 0
Foreign Exchange Effects -0.111 0.617 0.093 -0.018
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -65.165 -28.597 -253.21 -170.744 -89.869
Cash From Operating Activities -31.65 30.799 -172.888 -117.314 -54.662
Cash From Operating Activities 3.701 15.487 11.665 7.951 3.917
Amortization 0.592 2.352 1.74 1.137 0.544
Deferred Taxes 0 0 0 0
Non-Cash Items 32.983 155.375 125.535 88.261 43.346
Cash Taxes Paid 0.002 0.038 0.003 0.002
Cash Interest Paid 0.594 4.778 3.527 2.866 0.594
Changes in Working Capital -3.761 -113.818 -58.618 -43.919 -12.6
Cash From Investing Activities -287.549 194.906 99.797 -22.174 78.856
Capital Expenditures -2.705 -11.955 -9.453 -6.13 -1.772
Other Investing Cash Flow Items, Total -284.844 206.861 109.25 -16.044 80.628
Cash From Financing Activities -7.325 245.933 308.423 306.965 -7.577
Financing Cash Flow Items -9.173 -168.954 -168.43 -167.966 -15.337
Issuance (Retirement) of Stock, Net 1.848 101.317 101.316 99.394 7.76
Foreign Exchange Effects -0.154 -0.111 -0.043 -0.022 -0.126
Net Change in Cash -326.678 471.527 235.289 167.455 16.491
Issuance (Retirement) of Debt, Net 313.57 375.537 375.537
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fidelity Management & Research Company LLC Investment Advisor 14.9052 21307519 16360 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.4574 13519789 736550 2022-12-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 8.1692 11678259 521564 2022-12-31 MED
Bellevue Asset Management AG Investment Advisor 6.8161 9743900 280500 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.986 7127720 135266 2022-12-31 LOW
ClearBridge Investments, LLC Investment Advisor/Hedge Fund 3.7954 5425642 -348250 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.9511 4218729 457774 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.9049 4152607 -508999 2022-12-31 LOW
Tweedy, Browne Company LLC Investment Advisor 2.4771 3541136 818148 2022-12-31 LOW
ARK Investment Management LLC Investment Advisor 1.8702 2673538 -1039569 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.408 2012723 111580 2022-12-31 LOW
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 1.3946 1993600 1224700 2022-12-31 LOW
Camber Capital Management LP Hedge Fund 1.3466 1925000 0 2022-12-31 MED
First Trust Advisors L.P. Investment Advisor 1.2458 1780933 -296327 2022-12-31 LOW
Macquarie Investment Management Investment Advisor 1.0435 1491687 657646 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.907 1296647 465428 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.8788 1256268 53922 2022-12-31 LOW
Deep Track Capital LP Hedge Fund 0.8435 1205773 1205773 2022-12-31 MED
Renaissance Technologies LLC Hedge Fund 0.8246 1178814 311100 2022-12-31 HIGH
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.7966 1138714 15634 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

28,142.35 Price
+0.210% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,649.60 Price
+0.710% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

XRP/USD

0.39 Price
+3.570% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00375

Gold

1,966.59 Price
-0.560% 1D Chg, %
Biaya inap posisi Long -0.0172%
Biaya inap posisi short 0.0089%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda